Ipsen at a glance

Innovation for

patient care

Press releases

29 October 2014

Ipsen: sales in the 3rd quarter and first nine months of 2014

22 October 2014

Lexicon and Ipsen enter into ex-North America/Japan licensing and commercialization agreement for telotristat etiprate

YOU ARE ON IPSEN'S CORPORATE WEBSITE

The corporate website is governed by the International Federation of Pharmaceutical Manufacturers & Associations code of practice.
Certain information provided on this website may not be strictly in conformity with the French regulations on advertising.

> Close